# A Trial of SHR-1210 in Combination With SHR6390 in Patients With Advanced CRC, NSCLC and HCC

> **NCT03601598** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Harbin Medical University** · enrollment: 41 (estimated)

## Conditions studied

- CRC
- HCC
- NSCLC

## Interventions

- **DRUG:** SHR-1210
- **DRUG:** SHR6390

## Key facts

- **NCT ID:** NCT03601598
- **Lead sponsor:** Harbin Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-07-30
- **Primary completion:** 2019-07-30
- **Final completion:** 2020-07-30
- **Target enrollment:** 41 (ESTIMATED)
- **Last updated:** 2018-07-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03601598

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03601598, "A Trial of SHR-1210 in Combination With SHR6390 in Patients With Advanced CRC, NSCLC and HCC". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03601598. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*